sur BIOMERIEUX (EPA:BIM)
BioMérieux Launches WATCHFIRE™: A New PCR Test for Wastewater Surveillance
BioMérieux, a leader in in vitro diagnostics, has announced the launch of WATCHFIRE™, a molecular testing solution designed to detect viruses and bacteria in wastewater. The WATCHFIRE™ Respiratory Panel targets 22 pathogens and operates on the BIOFIRE® FILMARRAY® TORCH system, using FIREWORKS™ software for real-time pathogen monitoring.
This testing method, known as Wastewater and Environmental Surveillance (WES), gained prominence during the SARS-CoV-2 pandemic. It complements clinical surveillance and is particularly valuable in resource-limited settings, offering crucial health insights and aiding public health authorities in making informed decisions.
WATCHFIRE™ enables decentralized or near-source lab testing with a multiplex PCR test that delivers results in about 45 minutes. The panel will be available globally in Q2 2025, followed by a gastrointestinal panel in Q3.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BIOMERIEUX